Glucagon-like Peptide 1 (GLP-1): An Intestinal Hormone, Signalling Nutritional Abundance, with an Unusual Therapeutic Potential

Author： Holst J.J.  

Publisher： Elsevier

ISSN： 1043-2760

Source： Trends in Endocrinology and Metabolism, Vol.10, Iss.6, 1999-08, pp. : 229-235

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Harnessing the Therapeutic Potential of Glucagon-Like Peptide-1: A Critical Review

By Baggio L.L.   Drucker D.J.  

Treatments in Endocrinology, Vol. 1, Iss. 2, 2002-02 ,pp. : 117-125

Adis International

Access to resources Recommend Favorite

Treatment of Type 1 Diabetic Patients with Glucagon-Like Peptide-1 (GLP-1) and GLP-1R Agonists

By  

Current Diabetes Reviews, Vol. 5, Iss. 4, 2009-11 ,pp. : 266-275

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Coagonists of Glucagon and GLP-1

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 12, Iss. 2, 2015-01 ,pp. : 126-133

Bentham Science Publishers

Access to resources Recommend Favorite

Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in the Treatment of Obese Women with Polycystic Ovary Syndrome

By  

Current Vascular Pharmacology, Vol. 15, Iss. 3, 2017-04 ,pp. : 218-229

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of Glucagon-like Peptide-2 (GLP-2) on Diurnal SGLT1 Expression

By Ramsanahie Anthony   Berger Urs   Zinner Michael   Whang Edward   Rhoads David   Ashley Stanley  

Digestive Diseases and Sciences, Vol. 49, Iss. 11-12, 2004-11 ,pp. : 1731-1737

Springer Publishing Company

Access to resources Recommend Favorite